Europe’s Regulatory Body Signals Shift To ‘Weight of Evidence’ Model For Drug Approvals—How Does It Affect Psychedelic Medicines?

The European Medicines Agency is taking steps to rethink how certain high-need medicines reach patients, with a new concept paper proposing a more flexible, evidence-based pathway for cancer therapies. The post Europe’s Regulatory Body Signals Shift To ‘Weight of Evidence’ Model For Drug Approvals—How Does It Affect Psychedelic Medicines? appeared first on Psychedelic Health.